<?xml version="1.0" encoding="UTF-8"?>
<ack>
 <title>Declaration of interests</title>
 <p>KLO has received grant funding from GlaxoSmithKline and Pfizer and participates on technical advisory boards for Merck, Sanofi-Pasteur, PATH, Affinivax, and ClearPath. MDK has received funding for consultancies from Merck, Pfizer, and Novartis and grant funding from Merck. LLH has received grant funding from Pfizer and GlaxoSmithKline. KLK has received grant funding from Merck Sharp &amp; Dohme. SAMad has received honorarium for advisory board from the Bill &amp; Melinda Gates Foundation, Pfizer, Medimmune, and Novartis; institutional grants from GlaxoSmithKline, Novartis, Pfizer, Minervax, and Bill &amp; Melinda Gates Foundation; and speakers bureau for Sanofi Pasteur and GlaxoSmithKline. WAB reported funding from Sanofi, PATH, Bill &amp; Melinda Gates Foundation, and contributions to contemporaneous studies from Serum Institute of India, Roche, and Sanofi. All other authors declare no competing interests.</p>
</ack>
